Lyell Immunopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lyell Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Lyell Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 256M shares, a 1.99% increase year-over-year.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 251M shares, a 1.58% increase from 2022.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 247M shares, a 81.8% increase from 2021.
  • Lyell Immunopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 136M shares, a 925% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 256M +4.99M +1.99% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 255M +5.19M +2.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 254M +4.66M +1.87% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 251M +3.9M +1.58% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 251M +3M +1.21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 250M +3.89M +1.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 250M +5.41M +2.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 247M +111M +81.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 248M +8.94M +3.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 246M +204M +477% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 244M +227M +1314% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 136M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 239M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 42.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 17.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.